These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 8070470
1. Prognostic value of plasma neuropeptide-Y in coronary care unit patients with and without acute myocardial infarction. Ullman B, Hulting J, Lundberg JM. Eur Heart J; 1994 Apr; 15(4):454-61. PubMed ID: 8070470 [Abstract] [Full Text] [Related]
2. Elevation of plasma neuropeptide Y-like immunoreactivity and noradrenaline during myocardial ischaemia in man. Ullman B, Franco-Cereceda A, Hulting J, Lundberg JM, Sollevi A. J Intern Med; 1990 Dec; 228(6):583-9. PubMed ID: 2280235 [Abstract] [Full Text] [Related]
3. Plasma neuropeptide Y on admission to a coronary care unit: raised levels in patients with left heart failure. Hulting J, Sollevi A, Ullman B, Franco-Cereceda A, Lundberg JM. Cardiovasc Res; 1990 Feb; 24(2):102-8. PubMed ID: 2328516 [Abstract] [Full Text] [Related]
4. Response of plasma neuropeptide Y and noradrenaline to dynamic exercise and ramipril treatment in patients with congestive heart failure. Ullman B, Lindvall K, Lundberg JM, Sigurdsson A, Swedberg K. Clin Physiol; 1994 Mar; 14(2):123-34. PubMed ID: 8205743 [Abstract] [Full Text] [Related]
5. [Variations in neuropeptide Y plasma levels in acute myocardial infarction]. Bastagli L, Degiovanni M, Vallar G, De Iasio R, Boschi S, Puddu P. Cardiologia; 1992 Nov; 37(11):809-12. PubMed ID: 1298554 [Abstract] [Full Text] [Related]
6. Neuropeptide Y, noradrenaline and invasive haemodynamic data in mild to moderate chronic congestive heart failure. Ullman B, Jensen-Urstad M, Hulting J, Lundberg JM. Clin Physiol; 1993 Jul; 13(4):409-18. PubMed ID: 8370239 [Abstract] [Full Text] [Related]
7. Neurohormonal activation in heart failure after acute myocardial infarction treated with beta-receptor antagonists. Persson H, Andréasson K, Kahan T, Eriksson SV, Tidgren B, Hjemdahl P, Hall C, Erhardt L. Eur J Heart Fail; 2002 Jan; 4(1):73-82. PubMed ID: 11812667 [Abstract] [Full Text] [Related]
8. Plasma neuropeptide Y levels in the acute and early convalescent phase after myocardial infarction. Omland T, Opstad K, Dickstein K. Am Heart J; 1994 Apr; 127(4 Pt 1):774-9. PubMed ID: 8154414 [Abstract] [Full Text] [Related]
9. [Evaluation of plasma neuropeptide Y levels in patients with congestive heart failure]. Liu JJ, Shi SG, Han QD. Zhonghua Nei Ke Za Zhi; 1994 Oct; 33(10):687-9. PubMed ID: 7712919 [Abstract] [Full Text] [Related]
10. [Neuropeptide Y and heart failure]. Bastagli L, Degiovanni M, Vallar G, Zambrini L, Pepe G, De Iasio R, Boschi S, Puddu P. Cardiologia; 1992 Nov; 37(11):813-5. PubMed ID: 1298555 [Abstract] [Full Text] [Related]
11. [Plasma levels of neuropeptide Y i patients with current myocardial infarction]. Halawa B, Salomon P. Pol Arch Med Wewn; 2001 Feb; 105(2):117-22. PubMed ID: 11505745 [Abstract] [Full Text] [Related]
12. Plasma immunoreactive neuropeptide Y in congestive heart failure at rest and during exercise. Madsen BK, Husum D, Videbaek R, Stokholm KH, Saelsen L, Christensen NJ. Scand J Clin Lab Invest; 1993 Oct; 53(6):569-76. PubMed ID: 8266002 [Abstract] [Full Text] [Related]
20. Blood lactate is a predictor of short-term mortality in patients with myocardial infarction complicated by heart failure but without cardiogenic shock. Gjesdal G, Braun OÖ, Smith JG, Scherstén F, Tydén P. BMC Cardiovasc Disord; 2018 Jan 18; 18(1):8. PubMed ID: 29347907 [Abstract] [Full Text] [Related] Page: [Next] [New Search]